TrialScientific reports2018

Adjunctive use of celecoxib with anti-tuberculosis drugs: evaluation in a whole-blood bactericidal activity model.

Claire M Naftalin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.